Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Altaire Pharmaceuticals, Inc.
FDA Inspection
•Altaire Pharmaceuticals, Inc.•April 21, 2026

Altaire Pharmaceuticals, Inc. – FDA Inspection, Apr 21, 2026

Record Details

This FDA Inspection record concerns Altaire Pharmaceuticals, Inc., with an inspection on April 21, 2026, issued by the New York District Office, covering human drugs.

Company
Altaire Pharmaceuticals, Inc.
Inspection Date
April 21, 2026
Product Type
Human Drugs
Office
New York District Office
Person
  • Bijoy Panicker
View Company Profile

ID · 41e19a6e-ba33-47a8-ad24-842a94d518b4

Inspection Facts

Inspection number
1314330
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

8
  1. 21 CFR 211.100(a)Absence of Written Procedures
  2. 21 CFR 211.113(b)Procedures for sterile drug products
  3. 21 CFR 211.192Investigations of discrepancies, failures
  4. 21 CFR 211.22(d)Procedures not in writing, fully followed
  5. 21 CFR 211.25(a)Training , Education , Experience overall
  6. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  7. 21 CFR 211.42(c)(10)(v)Cleaning System
  8. 21 CFR 211.68(b)Computer control of master formula records

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Altaire Pharmaceuticals, Inc.

13
DateClassificationOfficeProject area
October 21, 2024NAICenter for Devices and Radiological HealthCompliance: Devices
February 11, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 19, 2019OAICenter for Veterinary MedicineGeneric Drug Evaluation
March 9, 2017VAICenter for Veterinary MedicineMonitoring of Marketed Animal Drugs, Feed, and Devices
December 15, 2015VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 13 other inspections on the company page
Other documents for Altaire Pharmaceuticals, Inc.
  • FDA Inspection 1251507 - 2024-10-21
  • FDA Inspection 1162640 - 2022-02-11
  • FDA Inspection 1089315 - 2019-04-19
  • FDA Inspection 1005208 - 2017-03-09
  • FDA Inspection 955795 - 2015-12-15

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Altaire Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.